Expression of GPSM3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

GPSM3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 27.59

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

26.9

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	101.5
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	94.6
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	75.6
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	74.5
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	57.8
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	55.4
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	53.6
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	53.2
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	52.1
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	51.6
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	47.8
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	47.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	46.4
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	44.7
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	43.0
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	42.3
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	41.9
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	41.6
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	41.4
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	41.2
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	40.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	39.9
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	39.6
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	39.3
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	39.2
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	37.8
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	37.1
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	35.3
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	34.8
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	34.6
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	34.4
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	34.2
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	33.9
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	32.7
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	32.5
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	32.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	32.4
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	32.2
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	32.1
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	32.0
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	31.9
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	31.5
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	31.4
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	31.4
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	31.2
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	31.1
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	30.6
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	30.3
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	30.2
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	29.7
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	29.6
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	29.5
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	29.1
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	28.4
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	28.3
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	28.2
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	28.2
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	28.1
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	28.0
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	27.8
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	27.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	27.5
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	27.3
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	26.9
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	26.7
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	26.6
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	26.5
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	26.5
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	26.3
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	26.1
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	26.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	25.9
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	25.7
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	25.6
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	25.3
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	25.0
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	24.2
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	22.8
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	22.6
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	22.4
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	22.3
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	22.0
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	21.1
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	21.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	20.8
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	20.3
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	20.3
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	20.3
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	19.9
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	19.8
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	19.7
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	19.7
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	19.3
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	19.1
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	18.6
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	18.4
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	18.1
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	17.9
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	17.8
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	17.6
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	17.5
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	17.2
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	16.9
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	16.4
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	16.4
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	16.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	16.2
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	16.0
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	16.0
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	15.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	14.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	14.2
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	13.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	13.7
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	13.6
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	13.2
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	12.8
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	12.6
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	12.5
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	12.3
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	12.3
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	11.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	11.6
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	11.3
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	10.9
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	10.6
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	10.4
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	9.7
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	9.7
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	9.7
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	9.2
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	9.0
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	8.5
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	8.0
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	7.9
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	7.7
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	7.6
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	7.0
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	5.9
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	5.0
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	4.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

GPSM3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4.25

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

4.0

Number of samples

Samples

Sample	Description	TPM
AK185	N, NA, stage:NA, alive, 330 days	13.8
AK188	N, NA, stage:NA, alive, 420 days	11.7
AK030	N, NA, stage:NA, dead, 120 days	10.7
AK005	N, NA, stage:NA, dead, 240 days	9.8
AK195	N, NA, stage:NA, dead, 390 days	8.1
AK236	N, NA, stage:NA, dead, 360 days	7.6
AK167	N, NA, stage:NA, dead, 180 days	5.9
AK085	N, NA, stage:NA, alive, 660 days	5.7
AK153	N, NA, stage:NA, dead, 240 days	5.6
AK003	N, NA, stage:NA, dead, 600 days	5.6
AK124	N, NA, stage:NA, alive, 1920 days	5.3
AK134	N, NA, stage:NA, dead, 360 days	5.2
AK072	N, NA, stage:NA, dead, 150 days	5.1
AK066	N, NA, stage:NA, alive, 960 days	5.1
AK091	N, NA, stage:NA, dead, 210 days	5.1
AK139	N, NA, stage:NA, dead, 270 days	4.9
AK183	N, NA, stage:NA, alive, 360 days	4.8
AK051	N, NA, stage:NA, dead, 360 days	4.8
AK133	N, NA, stage:NA, dead, 360 days	4.6
AK076	N, NA, stage:NA, alive, 660 days	4.4
AK103	N, NA, stage:NA, alive, 1320 days	4.4
AK227	N, NA, stage:NA, alive, 300 days	4.3
AK218	N, NA, stage:NA, dead, 180 days	4.2
AK079	N, NA, stage:NA, dead, 210 days	4.1
AK178	N, NA, stage:NA, dead, 240 days	4.0
AK055	N, NA, stage:NA, dead, 240 days	3.9
AK068	N, NA, stage:NA, alive, 360 days	3.8
AK071	N, NA, stage:NA, dead, 540 days	3.6
AK199	N, NA, stage:NA, alive, 1860 days	3.5
AK149	N, NA, stage:NA, dead, 420 days	3.4
AK098	N, NA, stage:NA, dead, 660 days	3.3
AK216	N, NA, stage:NA, dead, 360 days	3.0
AK099	N, NA, stage:NA, dead, 420 days	2.9
AK231	N, NA, stage:NA, dead, 240 days	2.7
AK049	N, NA, stage:NA, dead, 180 days	2.7
AK081	N, NA, stage:NA, dead, 180 days	2.6
AK100	N, NA, stage:NA, alive, 960 days	2.5
AK088	N, NA, stage:NA, dead, 360 days	2.5
AK173	N, NA, stage:NA, dead, 180 days	2.5
AK015	N, NA, stage:NA, alive, 720 days	2.4
AK158	N, NA, stage:NA, dead, 360 days	2.4
AK006	N, NA, stage:NA, dead, 360 days	2.4
AK053	N, NA, stage:NA, dead, 300 days	2.3
AK213	N, NA, stage:NA, alive, 2010 days	2.3
AK123	N, NA, stage:NA, dead, 180 days	2.3
AK165	N, NA, stage:NA, alive, 360 days	2.2
AK035	N, NA, stage:NA, dead, 210 days	2.1
AK226	N, NA, stage:NA, dead, 360 days	2.0
AK041	N, NA, stage:NA, alive, 810 days	1.9
AK089	N, NA, stage:NA, dead, 330 days	1.9
AK074	N, NA, stage:NA, alive, 300 days	1.8
AK102	N, NA, stage:NA, alive, 1740 days	1.7
AK043	N, NA, stage:NA, alive, 660 days	1.3
AK205	N, NA, stage:NA, dead, 120 days	1.3
AK142	N, NA, stage:NA, alive, 90 days	1.3
AK117	N, NA, stage:NA, dead, 210 days	1.1
AK002	N, NA, stage:NA, dead, 570 days	1.1
AK156	N, NA, stage:NA, dead, 330 days	1.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0168380003	Tumor	1.5
CPT0168480003	Tumor	1.4
CPT0162020003	Tumor	1.4
CPT0218330004	Tumor	1.3
CPT0125570003	Tumor	1.2
CPT0093450003	Tumor	1.0
CPT0216920008	Tumor	1.0
CPT0127480003	Tumor	0.9
CPT0189650004	Tumor	0.9
CPT0125510003	Tumor	0.9
CPT0219080004	Tumor	0.9
CPT0225760003	Tumor	0.9
CPT0228220003	Tumor	0.8
CPT0190360004	Tumor	0.8
CPT0206670004	Tumor	0.8
CPT0206230003	Tumor	0.7
CPT0205450004	Tumor	0.7
CPT0205890003	Tumor	0.7
CPT0087570003	Tumor	0.7
CPT0089150003	Tumor	0.7
CPT0162100003	Tumor	0.7
CPT0167970003	Tumor	0.7
CPT0093550003	Tumor	0.6
CPT0087730003	Tumor	0.6
CPT0104220003	Tumor	0.6
CPT0064650003	Tumor	0.6
CPT0167640003	Tumor	0.6
CPT0186100003	Tumor	0.6
CPT0206450003	Tumor	0.6
CPT0209440003	Tumor	0.6
CPT0217060003	Tumor	0.5
CPT0224540004	Tumor	0.5
CPT0127420003	Tumor	0.5
CPT0196850003	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0225730003	Tumor	0.4
CPT0221180003	Tumor	0.4
CPT0125220003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0218690004	Tumor	0.4
CPT0218670003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0189460003	Tumor	0.3
CPT0167750004	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0199770003	Tumor	0.2
CPT0189750004	Tumor	0.2
CPT0217000004	Tumor	0.2
CPT0206330003	Tumor	0.2
CPT0206000004	Tumor	0.2
CPT0205570003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0206560003	Tumor	0.1
CPT0208980003	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0168080003	Tumor	0.1
CPT0224330003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0175060003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0078580003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0206110003	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0204360003	Normal	-0.1
CPT0201710003	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0168720003	Tumor	-0.2
CPT0064890003	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0093590003	Tumor	-0.3
CPT0224600003	Tumor	-0.3
CPT0207030003	Tumor	-0.3
CPT0093510003	Tumor	-0.3
CPT0207090003	Tumor	-0.3
CPT0218890004	Tumor	-0.3
CPT0071100003	Tumor	-0.4
CPT0161730003	Tumor	-0.4
CPT0189250003	Tumor	-0.4
CPT0205780003	Tumor	-0.4
CPT0167530003	Tumor	-0.4
CPT0123530003	Tumor	-0.4
CPT0171580008	Tumor	-0.4
CPT0167860004	Tumor	-0.5
CPT0217710008	Tumor	-0.5
CPT0204400003	Normal	-0.5
CPT0182550003	Tumor	-0.5
CPT0182500003	Tumor	-0.5
CPT0189850004	Tumor	-0.5
CPT0168590003	Tumor	-0.5
CPT0217100003	Tumor	-0.6
CPT0204390003	Normal	-0.6
CPT0206780003	Tumor	-0.6
CPT0204330003	Normal	-0.6
CPT0218770003	Tumor	-0.7
CPT0204370003	Normal	-0.7
CPT0204340003	Normal	-0.7
CPT0104330003	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0162140003	Tumor	-0.8
CPT0204410003	Normal	-0.9
CPT0204420003	Normal	-1.0
CPT0224390004	Tumor	-1.1
CPT0204380003	Normal	-1.2
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis